Natl. Oxygen (507813)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹135 |
| Market Cap | ₹68.07 Cr |
| P/E Ratio | 0 |
| ROCE | -21.54% |
| ROE | -29.84% |
| Dividend Yield | 0% |
| Profit Growth | 21.72% |
| Debt/Equity | — |
| Sales Growth | -53.25% |
| 52-Week Range | ₹57 — ₹135 |
| Sector | Chemicals & Petrochemicals |
Strengths
- Stock has recovered sharply from ₹57 to ₹135, showing market optimism about a possible turnaround.
- Piotroski F-Score of 5/9 suggests some financial health across the nine indicators.
- Profit growth of +21.72% may indicate the loss is narrowing year-on-year.
- Latest quarter sales of ₹5 Cr show the business is still operational, not dormant.
Concerns
- Sales growth of -53.25% shows a severely shrinking business.
- Negative ROE of -29.84% and ROCE of -21.54% reflect capital destruction.
- Latest quarter net loss of ₹2 Cr on sales of ₹5 Cr means weak underlying economics.
- Zero dividend, unavailable book value, and insufficient data make fundamental valuation impossible.
AI Analysis
Let's be plain: Natl. Oxygen fails the first test — I cannot value what I cannot see. The company operates in industrial gases, but the numbers are uninviting. Price is ₹135, market cap is ₹68 Cr, yet the latest quarter shows sales of only ₹5 Cr and a net loss of ₹2 Cr. Annualise that loss, and you have a business destroying capital. ROE is -29.84%, ROCE is -21.54%, there is no dividend, and we are not even given book value or debt-equity. For Graham, margin of safety comes from a solid balance sheet and predictable earnings, not from hope. Sales growth is -53.25%; when a business loses half its revenue, that is a genuine crisis or a structural shift. Profit growth of +21.72% may look nice, but with a loss-making base, it is far less meaningful. The Piotroski F-score of 5/9 is mediocre — it hints at some improvement, but it is not a clean bill of health. Meanwhile, the stock trades near the top of its 52-week range, up from ₹57 to ₹135. The market seems to anticipate a turnaround. Buffett would say I do not invest in anticipation; I invest in evidence. Where are the rising sales, durable margins, and net cash? Not here. FairStock itself says insufficient data. This looks like a speculative instrument, not an investment. If the company genuinely restructures, we need several quarters of positive operating cash flow and margin recovery. Until then, I prefer to stay on the sidelines. A ₹68 Cr market cap on a loss-making gas company is not cheap by any Graham metric; it is a bet on the future, and I do not bet without numbers.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer